Sociodemographic characteristics and longitudinal progression of multimorbidity: A multistate modelling analysis of a large primary care records dataset in England
PLOS Medicine · 03.11.2023 · 20 (11) · e1004310
DOI: 10.1371/journal.pmed.1004310 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, online erschienen am 03.11.2023. Verfasst von Sida Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Heart Failure, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, UK Research and Innovation, National Institute for Health Research Collaboration Applied Research Collaboration West Midlands.
Abstract (Originalsprache)
Background
Multimorbidity, characterised by the coexistence of multiple chronic conditions in an individual, is a rising public health concern. While much of the existing research has focused on cross-sectional patterns of multimorbidity, there remains a need to better understand the longitudinal accumulation of diseases. This includes examining the associations between important sociodemographic characteristics and the rate of progression of chronic conditions. Methods and findings We utilised electronic primary care records from 13.48 million participants in England, drawn from the Clinical Practice Research Datalink (CPRD Aurum), spanning from 2005 to 2020 with a median follow-up of 4.71 years (IQR: 1.78, 11.28). The study focused on 5 important chronic conditions: cardiovascular disease (CVD), type 2 diabetes (T2D), chronic kidney disease (CKD), heart failure (HF), and mental health (MH) conditions. Key sociodemographic characteristics considered include ethnicity, social and material deprivation, gender, and age. We employed a flexible spline-based parametric multistate model to investigate the associations between these sociodemographic characteristics and the rate of different disease transitions throughout multimorbidity development. Our findings reveal distinct association patterns across different disease transition types. Deprivation, gender, and age generally demonstrated stronger associations with disease diagnosis compared to ethnic group differences. Notably, the impact of these factors tended to attenuate with an increase in the number of preexisting conditions, especially for deprivation, gender, and age. For example, the hazard ratio (HR) (95% CI; p -value) for the association of deprivation with T2D diagnosis (comparing the most deprived quintile to the least deprived) is 1.76 ([1.74, 1.78]; p < 0.001) for those with no preexisting conditions and decreases to 0.95 ([0.75, 1.21]; p = 0.69) with 4 preexisting conditions. Furthermore, the impact of deprivation, gender, and age was typically more pronounced when transitioning from an MH condition. For instance, the HR (95% CI; p -value) for the association of deprivation with T2D diagnosis when transitioning from MH is 2.03 ([1.95, 2.12], p < 0.001), compared to transitions from CVD 1.50 ([1.43, 1.58], p < 0.001), CKD 1.37 ([1.30, 1.44], p < 0.001), and HF 1.55 ([1.34, 1.79], p < 0.001). A primary limitation of our study is that potential diagnostic inaccuracies in primary care records, such as underdiagnosis, overdiagnosis, or ascertainment bias of chronic conditions, could influence our results.
Conclusions
Our results indicate that early phases of multimorbidity development could warrant increased attention. The potential importance of earlier detection and intervention of chronic conditions is underscored, particularly for MH conditions and higher-risk populations. These insights may have important implications for the management of multimorbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
- Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
- Nuffield Department for Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
- Health Data Research, Oxford, United Kingdom.
ORCID-Profile: Sida Chen, Tom Marshall, Christopher Jackson, Jennifer Cooper, Francesca Crowe, Krish Nirantharakumar, Catherine L Saunders, Simon Griffin, Christopher Yau, Jessica K Barrett
Förderung
- Medical Research Council
- UK Research and Innovation
- National Institute for Health Research Collaboration Applied Research Collaboration West Midlands
- National Institute for Health Research
Zitieren
APA
Chen, S., Marshall, T., Jackson, C., Cooper, J., Crowe, F., Nirantharakumar, K., Saunders, C. L., Kirk, P., Richardson, S., Edwards, D., Griffin, S., Yau, C., & Barrett, J. K. (2023). Sociodemographic characteristics and longitudinal progression of multimorbidity: A multistate modelling analysis of a large primary care records dataset in England. PLOS Medicine, 20(11), e1004310. https://doi.org/10.1371/journal.pmed.1004310
Vancouver
Chen S, Marshall T, Jackson C, Cooper J, Crowe F, Nirantharakumar K, et al. Sociodemographic characteristics and longitudinal progression of multimorbidity: A multistate modelling analysis of a large primary care records dataset in England. PLOS Medicine. 2023;20(11):e1004310. doi:10.1371/journal.pmed.1004310
BibTeX
@article{Chen2023,
author = {Chen, Sida and Marshall, Tom and Jackson, Christopher and Cooper, Jennifer and Crowe, Francesca and Nirantharakumar, Krish and Saunders, Catherine L and Kirk, Paul and Richardson, Sylvia and Edwards, Duncan and Griffin, Simon and Yau, Christopher and Barrett, Jessica K},
title = {Sociodemographic characteristics and longitudinal progression of multimorbidity: A multistate modelling analysis of a large primary care records dataset in England},
journal = {PLOS Medicine},
year = {2023},
volume = {20},
number = {11},
pages = {e1004310},
doi = {10.1371/journal.pmed.1004310}
}
EUVIMED